NCT07881757: A Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Do Not Use a Breathing Machine (PAP) (VESPER-OSA 2)
- State
- Under way
- Phase
- Phase 3
- People
- 258 planned
- Started
- 19 Oct 2026
- Primary completion
- 1 Jun 2028
- Arms
- Berobenatide
- Results
- None posted
- 19 Oct 2026: Trial registered
- 19 Oct 2026: Trial started